Compare VKTX & NP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VKTX | NP |
|---|---|---|
| Founded | 2012 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 4.4B |
| IPO Year | 2014 | 2025 |
| Metric | VKTX | NP |
|---|---|---|
| Price | $25.03 | $29.06 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 21 | 13 |
| Target Price | ★ $94.50 | $34.00 |
| AVG Volume (30 Days) | ★ 7.9M | 507.3K |
| Earning Date | 10-26-2026 | 10-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.16 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $26.63 |
| Revenue Next Year | N/A | $17.59 |
| P/E Ratio | ★ N/A | $184.25 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $25.28 | $14.78 |
| 52 Week High | $43.15 | $35.15 |
| Indicator | VKTX | NP |
|---|---|---|
| Relative Strength Index (RSI) | 35.80 | 49.99 |
| Support Level | N/A | $26.86 |
| Resistance Level | $34.00 | $34.96 |
| Average True Range (ATR) | 1.46 | 0.93 |
| MACD | -0.49 | 0.33 |
| Stochastic Oscillator | 1.63 | 76.67 |
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
Neptune Insurance Holdings Inc is a high-growth, profitable, data-driven MGA that offers residential and commercial insurance products, including primary flood insurance, excess flood insurance and parametric earthquake insurance, distributed through a nationwide network of agencies in the United States. The company underwrites and administers the issuance of insurance policies on behalf of a diverse panel of insurance and reinsurance companies and does not take any balance sheet insurance risk or have claims handling responsibility relating to the policies it sells.